Big Move For Alterity Therapeutics Limited
Alterity Therapeutics Limited (ATHE:NASDAQ) rocketted at $4.57, representing a gain of 52.8%. On Thu, Jan 30, 2025, ATHE:NASDAQ hit a New 2-Week High of $4.57. The stock got featured on our News Catalysts scanner on Thu, Jan 30, 2025 at 09:19 AM in the 'BIOTECH' category. From Thu, Jan 16, 2025, the stock recorded 44.44% Up Days and 60.00% Green Days
The stock spiked on Thu, Jan 30, 2025 at $5.87 with a volume of 22M+.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- Foxx Development Holdings Inc. (FOXX:NASDAQ), 121.11%
- Benson Hill Inc. (BHIL:NASDAQ), 119.44%
- Tectonic Therapeutic Inc Com (TECX:NASDAQ), 113.22%
- Alpha Modus Holdings Inc. (AMOD:NASDAQ), 103.9%
- Dominari Holdings Inc Com (DOMH:NASDAQ), 59.11%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 52.84%
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 52.78%
- F45 Training Holdings Inc. (FXLV:NYSE), 42.86%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 37.68%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 35.58%